Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, P.O. Box: 100, Tripoli, Lebanon.
Departments of Anesthesiology and Pharmacology, Medical College of Wisconsin, Milwaukee, USA.
Arch Biochem Biophys. 2018 Nov 1;657:41-55. doi: 10.1016/j.abb.2018.09.006. Epub 2018 Sep 11.
The uncoupling protein (UCP1) is a proton (H) transporter in the mitochondrial inner membrane. By dissipating the electrochemical H gradient, UCP1 uncouples respiration from ATP synthesis, which drives an increase in substrate oxidation via the TCA cycle flux that generates more heat. The mitochondrial uncoupling-mediated non-shivering thermogenesis in brown adipose tissue is vital primarily to mammals, such as rodents and new-born humans, but more recently additional functions in adult humans have been described. UCP1 is regulated by β-adrenergic receptors through the sympathetic nervous system and at the molecular activity level by nucleotides and fatty acid to meet thermogenesis needs. The discovery of novel UCP homologs has greatly contributed to the understanding of human diseases, such as obesity and diabetes. In this article, we review the progress made towards the molecular mechanism and function of the UCPs, in particular focusing on the influential contributions from Martin Klingenberg's laboratory. Because all members of the UCP family are potentially promising drug targets, we also present and discuss possible approaches and methods for UCP-related drug discovery.
解偶联蛋白 (UCP1) 是线粒体内膜中的质子 (H) 转运体。通过耗散电化学 H 梯度,UCP1 将呼吸作用与 ATP 合成解偶联,这通过 TCA 循环通量驱动底物氧化增加,从而产生更多热量。棕色脂肪组织中的线粒体解偶联介导的非颤抖性产热对哺乳动物(如啮齿动物和新生人类)至关重要,但最近在成年人类中描述了更多的功能。UCP1 通过交感神经系统被 β-肾上腺素能受体调节,在分子活性水平上被核苷酸和脂肪酸调节以满足产热需求。新型 UCP 同源物的发现极大地促进了对肥胖和糖尿病等人类疾病的分子机制和功能的理解。在本文中,我们回顾了 UCPs 的分子机制和功能的研究进展,特别是重点介绍了 Martin Klingenberg 实验室的重要贡献。由于 UCP 家族的所有成员都是有前途的药物靶点,我们还提出并讨论了 UCP 相关药物发现的可能方法和方法。